PDL BioPharma, Inc. Accrued Expenses

Accrued Expenses of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Accrued Expenses growth rates and interactive chart. Accrued expense is expense which has been incurred but not yet paid. Expense must be recorded in the accounting period in which it is incurred. Therefore, accrued expense must be recognized in the accounting period in which it occurs rather than in the following period in which it will be paid.

Highlights and Quick Summary

  • Accrued Expenses for the quarter ending March 30, 2019 was $30.9 Million (a -19.0% decrease compared to previous quarter)
  • Year-over-year quarterly Accrued Expenses decreased by -55.61%
  • Annual Accrued Expenses for 2011 was $121 Million (a -34.4% decrease from previous year)
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Accrued Expenses of PDL BioPharma, Inc.

Most recent Accrued Expensesof PDLI including historical data for past 10 years.

Interactive Chart of Accrued Expenses of PDL BioPharma, Inc.

PDL BioPharma, Inc. Accrued Expenses for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2019 $30.87
2017 $38.11
2012 $22.74 $69.53
2011 $120.87 $142.77 $150.75 $145.18 $120.87
2010 $184.25 $6.41 $184.25

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.